HCC heterogeneity: molecular pathogenesis and clinical implications.

Abstract excerpt

BACKGROUND: Hepatocellular carcinoma (HCC) poses a major challenge because of the extreme variability of the clinical outcome, which makes it difficult to properly stage the disease and thereby estimate the prognosis. There is growing evidence that this heterogeneous clinical behavior is attributable to several different biological pathways. A novel approach to mapping these differences is by investigating the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Mechanisms and Therapy
• Share to Fibroblast Growth Factor Research
• Share to Hepatocellular Carcinoma Treatment and Prognosis